Allogeneic Anti-CD7 CAR-T
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Allogeneic Anti-CD7 CAR-T, covering 2026-04-14 to 2026-04-14. Get the full timeline:
Most recent: Clinical Trial Update: Allogeneic Anti-CD7 CAR-T for Type 1 Diabetes [EARLY_Phase 1]